Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

v3.10.0.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2017
Mar. 15, 2018
Jun. 30, 2017
Document And Entity Information [Abstract]      
Entity Registrant Name Akers Biosciences, Inc.    
Entity Central Index Key 0001321834    
Document Type 10-K/A    
Document Period End Date Dec. 31, 2017    
Amendment Flag true    
Amendment Description

This Amendment No. 1 on Form 10-K/A (this “Form 10-K/A") amends and restates certain items noted below in the Annual Report on Form 10-K of Akers Biosciences, Inc. (the “Company”) for the fiscal year ended December 31, 2017, as originally filed with the Securities and Exchange Commission on April 3, 2018 (the “Original Filing”). This Form 10-K/A amends the Original Filing to reflect the correction of misstatements in the previously reported fiscal year 2017 financial statements related to the Company’s revenue, certain obligations and the value of certain inventory items. See Note 2 to the Consolidated Financial Statements included in Item 8 for additional information and a reconciliation of the previously reported amounts to the restated amounts.

 

For the convenience of the reader, this Form 10-K/A sets forth the Original Filing, as amended, in its entirety; however, this Form 10-K/A amends and restates only the following financial statements and disclosures that were impacted from the correction of the misstatements:

 

● Part I, Item 1A – Risk Factors
   
● Part II, Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations
   
● Part II, Item 8 - Financial Statements and Supplementary Data
   
● Part II, Item 9A - Controls and Procedures

 

In addition, the Company’s Chief Executive Officer and Chief Financial Officer have provided new certifications dated as of the date of this filing in connection with this Form 10-K/A (Exhibits 31.1, 31.2, 32.1 and 32.2), and the Company has provided its revised audited consolidated financial statements formatted in Extensible Business Reporting Language (XBRL) in Exhibit 101.

 

Except as described above, no other changes have been made to the Original Filing. This Form 10-K/A speaks as of the date of the Original Filing and does not reflect events that may have occurred after the date of the Original Filing, or modify or update any disclosures that may have been affected by subsequent events.

 

The Company is also concurrently filing amended Quarterly Reports on Form 10-Q for the quarterly periods ended June 30, 2017 and September 30, 2017 to restate the previously issued interim financial statements due to the accounting misstatements described above.

    
Current Fiscal Year End Date --12-31    
Entity a Well-known Seasoned Issuer No    
Entity a Voluntary Filer No    
Entity's Reporting Status Current Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 10,201,326
Entity Common Stock, Shares Outstanding   81,973,964  
Trading symbol AKER    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2017